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Plasminogen activation occurs through conversion of plasminogen to plasmin by plasminogen activators. 
In adult mammals, liver has been the only known site for plasminogen synthesis. Seminiferous tubules se- 
crete plasminogen activator, but are behind a barrier that excludes the entrance of many macromolecules 
to this tissue. Therefore, it became of interest to study the existence of plasminogen in this system. After 
metabolic labeling, a 90 kDa lysine-binding polypeptide was found. This protein could be immunoblotted 
by anti-plasminogen antibody, and was shown to possess urokinase-dependent proteolytic activity. The 
findings suggest hat plasminogen is synthesized by seminiferous tubules. We propose that local plasmino- 
gen synthesis may occur in tissues which are separated by specific anatomical barriers. 
Plasminogen synthesis (Seminiferous tubule, Testis) 
1. INTRODUCTION 
Plasminogen is a proenzyme, which is proteoly- 
tically activated by specific serine proteinases, the 
plasminogen activators, to plasmin, another serine 
proteinase capable of degrading e.g. polymerized 
fibrin in blood clots and known glycoproteins of 
the extracellular matrix [ 1,2]. The site of synthesis 
of plasminogen in circulation remained uncon- 
firmed for a long time, though this zymogen repre- 
sents the quantitatively most prominent proteolytic 
activity of plasma and of most extravascular fluids. 
It was not until 1980, when Raum et al. [3] demon- 
strated that liver is the principal source of human 
plasminogen. Simultaneously, Bohmfalk and Fuller 
[4] published their article describing synthesis of 
plasminogen by cultures of primary adult rat 
hepatocytes. Since then no new sites of synthesis 
have been detected in human. Valinsky and Reich 
[5] showed metabolically labeled plasminogen in 
the chick embryo and concluded that de novo syn- 
thesis occurs during the early phases of embryonic 
life. Isseroff and Rifkin [6] found plasminogen in 
the peripheral intracytoplasmic area of the basal 
keratinocytes of the skin, but failed to find any 
signs of plasminogen synthesis in cultures of epi- 
dermal cells. 
Spermatogenesis occurs in seminiferous tubules 
separated from circulation. The effectiveness of 
the barrier is clearly demonstrated by the fact that 
polypeptide structures of the developing spermato- 
genie cells are highly immunogenic to the host. It 
is therefore a matter of interest hat Sertoli cells in- 
side the tubular wall are capable of secreting 
plasminogen activators [7-91. The only 
well-characterized substrate apart from enzyme in- 
hibitors [lo] of these highly specific proteinases is 
plasminogen, and free diffusion of this zymogen 
or of other plasma macromolecules into the in- 
tratubular compartment has not been demonstrated 
[ 111. This led us to look for possible local synthesis 
of plasminogen by the seminiferous tubules and 
here we demonstrate the accumulation of metabol- 
ically labeled plasminogen in the culture medium 
of rat seminiferous tubules. 
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2. MATERIALS AND METHODS 3. RESULTS 
Male adult Wistar rats (2-12 months) were 
anesthesized with ether and killed by cardiac punc- 
ture. The testes were sterilely removed, and the 
seminiferous tubules were mechanically separated 
from the interstitial tissue in a petri dish under a 
stereomicroscope. The characteristic transillumina- 
tion pattern of the tubules [12] was identified and 
2 mm pieces of tubules were dissected representing 
stages II-VI, VII-VIII, IX-XII and XIII-I of the 
seminiferous epithets cycle [ 131. In each stage 
1 mm of the tubule corresponds to about 1 mg 
tissue protein 171. For the experiments, 50 pieces of 
each pool of stage were dissected. The tubule 
preparations do not contain significant amounts of 
interstitial Leydig cells as judged from their inabili- 
ty to respond to stimulation by the luteinizing hor- 
mone [14]. The tissue pieces were washed and in- 
cubated in 1 ml Eagle’s minimal essential medium 
lacking methionine and supplied with antibiotics, 
at 32’C in humidified 5% CO2 atmosphere. For 
metabolic labeling of the peptides, 40 pCi L-[35S]- 
methionine/ml (800 Cifmmol, Amersham, Eng- 
land) and the proteinase inhibitor aprotinin (100 
IU/ml, Bayer, Leverkusen, FRG) were added. 
After incubations of 24, 48 and 72 h, the super- 
natants were collected and centrifuged, first at 
500xg for 15 min and then at 1OOOOxg for 
30 min. Lysine-Sepharose (Pharmacia, Uppsala, 
Sweden) was added to the medium samples (100~1 
of 50% (v/v) particles/ml) and incubated over- 
night at 4OC. The beads were washed several times 
with phosphate buffer (0.05 M, pH 7.5) and finally 
with 0.3 M NaCl dissolved in the same buffer. 
Next, the beads were taken in nonreducing Laem- 
mli sample buffer 1151 or, when the activity of the 
preparation was not tested, the bound material was 
eluted with e-aminocaproic acid in distilled water 
(4x lOO$, 0.3 M) [16], and the proteins were 
precipitated by adding trichloroacetic acid to a 
final concentration of 5% and dissolved in the 
sample buffer. Plasminogen was identified from 
the samples by polyacrylamide gel electrophoresis 
followed by immunoblotting the protein on a 
nitrocellulose filter [ 171 with antihuman plasmino- 
gen (Dako, Denmark). I~unopr~ipitation was 
carried out with the IgG fraction of the above an- 
tiserum (purified by the protein A method) fol- 
lowed by capture with protein A-Sepharose (Phar- 
macia) .
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The lysine-Sepharose method used for obtaining 
sufficient amounts of plasminogen for the im- 
munological and radiographical analyses was sen- 
sitive enough to concentrate plasminogen from 500 
~1 rat plasma diluted 1: 10000 (approx. 10 ng) for 
visualization in immunoblotting (fig. la). The 
polypeptide doublet [la] bound from the culture 
medium of the seminiferous tubules comigrated 
with the one obtained from rat plasma (fig.2a). 
For the most part, it obviously represented plas- 
minogen derived from the extratubular structures 
such as disrupted capillaries and contaminating 
plasma. It was the only polypeptide visualized 
f z 
Fig.1. (a) Immunoblotting of plasminogen from rat 
plasma. Diluted samples of rat plasma (vol. 500 ~1) were 
treated with lysine-Sepharose and the immobilized pro- 
teins were electrophoresed in a 8% polyacrylamide gel, 
transferred to nitrocellulose and visualized by immuno- 
blotting. The samples contained about 1 /cg (l), 100 ng 
(2), and 10 ng (3) plasminogen. (b) The above samples 
(l-3) showed proteolytic activity after treatment with 
plasminogen activator in the zymography assay. Sample 
4 contains plasminogen bound from the conditioned 
medium of seminiferous tubules. The zymography assay 
[ZO] involves detection of proteolytic activity present in 
a polyacrylamide gel by an agarose gel overlay, which 
contains an opalescent substrate such as casein. Degra- 
dation of the substrate becomes visible as a ckar band 
over the proteinase. 
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Fig.2. (a) Immunoblotting of plasminogen in the condi- 
tioned medium of seminiferous tubules. The samples 
represent stages II-IV (I), VII-VIII (2), IX-XII (3), and 
XIII-I (4) of the seminiferous epithelial cycle. Sample 5 
represents plasminogen from rat plasma (about 100 ng). 
The seminiferous tubules (100 mg) were cultured in 
serum-free medium (1 ml) for 72 h and the plasminogen 
present in the growth medium was bound to Iysine- 
Sepharose particles. The bound material was eluted with 
E-aminocaproic acid followed by precipitation with 
trichloroacetic acid. The proteins were dissolved in sam- 
ple buffer and electrophoresed in a S-16% gradient 
polyacrylamide g l with a 3.5% stacking el. (b) Auto- 
radiography of the same nitrocellulose heet as ina. The 
radioactivity (samples I-4) comigrates with the 
plasminogen immunoreactivity. 
after protein staining of the polyacrylamide gel 
(not shown). After autoradiography of the im- 
munoblotting filter, a metabolically labeled pro- 
tein was seen to con&rate with the ~munor~c- 
tive protein (fig.Zb). 
The growth media from all four stage pools 
(II-VI, VII-VIII, IX-XII and XIII-I) contained 
roughly the same amount of the labeled protein, 
although electrophoretic analysis of the precipi- 
tated total proteins after 72 h labeling with 13%]- 
methionine showed differences between the pro- 
teins secreted into the conditioned media (fig.3) 
thus confirming the separation of the various 
stages of the seminiferous tubule. The secretion of 
the labeled protein increased with time, and it 
could be removed from the conditioned medium 
prior to the lysine-Sepharose concentration by im- 
munoprecipitation with purified anti-plasminogen- 
IgG (fig.4). 
The lysine-Sepharose bound protein both from 
rat plasma and from the medium samples was 
Fig.3. Autoradiography of the proteins secreted uring 
72 h by the same stage groups as in fig.2 (l-4). The 
samples were electrophoresed in an 8% polyacrylamide 
gel. Differences are seen between the proteins secreted 
by the various stage groups. 
found to possess proteolytic activity when tested in 
the z~ography assay (fig. lb), but only after treat- 
ment with plasminogen activator (54 kDa urokin- 
ase-type plasminogen activator, 60 000 IU/mg, 
Calbiochem, La Jolla, CA). Since aprotinin was 
present during the sample collectioni! the activity 
detected in the zymography assay was due to ac- 
tivation of plasminogen to plasmin in the gel. 
Plasminogen activator (1.0 IUlml) was present in 
the casein-agarose overlay to carry out this activa- 
tion. 
Taken together, we find in the spent media of rat 
seminiferous tubular segments a l~ine-binding E- 
aminocaproic acid eluting protein reacting in im- 
munoblotting with antiserum against plasminogen 
and possessing proteolytic activity after activation 
with plasminogen activator. This protein co- 
migrates with a metabolically labelled polypeptide 
precipitable with ~tipl~minogen antiserum. These 
195 
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Fig.4. (a) Immunoblotting of plasminogen showing ac- 
cumulation of the protein during incubation of the 
seminiferous tubules. The incubation periods were 24 h 
(l), 48 h (2), and 72 h (3). The antigenicity is removed 
by treatment of the conditioned medium with anti- 
human plasminogen and protein A-Sepharose (4). Sam- 
ple 5 shows plasminogen derived from rat plasma. (b) 
Autoradiography of the same nitrocellulose sheet as in a. 
The metabolically labeled band (b, l-3) comigrating with 
rat plasma plasminogen (a,S) is removed by an- 
tiplasminogen (b,4) together with the plasminogen im- 
munoreactivity (a,4). The lysine-Sepharose bound ma- 
terial was directly subjected to electrophoresis without 
elution with e-aminocaproic acid. This resulted in the ap- 
pearance of some additional metabolically labeled pro- 
teins with higher molecular mass into the autoradio- 
graphy. 
properties strongly suggest that the synthesized 
protein is plasminogen. 
4. DISCUSSION 
The seminiferous tubules consist of myoid cells 
surrounding the tubules, a thick basement mem- 
brane and cells inside the tubules. The spermato- 
gonia, preleptotene spermatocytes and the large 
Sertoli cells rest on the inner side of the basement 
membrane. During the very early phases of the 
maturation of the spermatogenic ells, the prelep- 
totene spermatocytes are detached from the base- 
ment membrane and become totally wrapped by 
the surrounding Sertoli cells [20]. These cells are 
tightly bound to each other by special attachment 
structures, which form the most effective part of 
the blood-testis barrier [21]. Urokinase-like plas- 
minogen activator can be immunochemically local- 
ized in Sertoli cells, where it is seen in Golgi-like 
structures of the cytoplasm [22]. The secretion of 
this proteinase from the separated seminiferous 
structures is cyclic and is most prominent from the 
stages VII-VIII [7-9,221. The secretion of 
plasminogen activator is at least partially regulated 
by the preleptotene primary spermatocytes [7]. In 
addition, Sertoli cells increase their plasminogen 
activator secretion after stimulation with the folli- 
cle stimulating hormone and cyclic AMP [8]. 
Potential targets for the action of plasminogen 
activation-mediated proteolysis are the matrix 
components during detachment of the primary 
spermatocytes from the basement membrane or 
dissolution of the intercellular junctions between 
the Sertoli cells, which occurs during the transport 
and maturation of the spermatocytes into the 
lumen of the tubules [7]. A role for the proteolytic 
activity in the modulation of cell-secreted proteins 
could also be anticipated [23,24]. The presence of 
plasminogen during all stages of maturation sug- 
gests that the regulation of proteolysis may occur 
via the action of plasminogen activator and/or an 
inhibitor of plasminogen activators. 
The cells secreting plasminogen remain unknown. 
In immunofluorescence or immunoperoxidase 
studies (not shown) the vascular and extracellular 
areas outside the seminiferous tubules could be 
stained with antiplasminogen. The amount possibly 
located inside the tubules may, however, be too 
small to be visualized with the staining methods 
and antisera currently at use. It is possible that the 
observed synthesis might occur in the metabolical- 
ly multipotent Sertoli cells, which are known to 
secrete .g. transferrin [25] and ceruloplasmin [26]. 
To our knowledge, the seminiferous tubule is the 
first extrahepatic site of plasminogen synthesis in 
mammals. Such local production could occur at 
places not reached by the circulating pool of 
plasminogen, such as the nervous system. Cells 
located behind the blood-brain barrier secrete 
plasminogen activators [24,27], which suggests 
that either these enzymes have another substrate 
apart from plasminogen or the local synthesis of 
plasminogen takes place in that organ as well. 
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